EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | N208658 | BOEHRINGER INGELHEIM PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. et al 1 patentANDA 212331, 212335, 213654, 215072empagliflozin, empagliflozin/linagliptin, empagliflozin/metformin, empagliflozin/linagliptin/metformin | D. Del. | 2021-10-22 | Active | — |
| D. Del. | 2021-03-09 | Terminated 2025-07-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$11.21
per ea
Lowest NADAC/Unit
$5.60
per ea
Brand NDCs
8
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00597028090SYNJARDY XR 10-1,000 MG TABLET | $11.21 | EA | Brand | — | 2026-10-21 |
| 00597028073SYNJARDY XR 10-1,000 MG TABLET | $11.21 | EA | Brand | — | 2026-10-21 |
| 00597029578SYNJARDY XR 25-1,000 MG TABLET | $11.19 | EA | Brand | — | 2026-10-21 |
| 00597029588SYNJARDY XR 25-1,000 MG TABLET | $11.19 | EA | Brand | — | 2026-10-21 |
| 00597029074SYNJARDY XR 5-1,000 MG TABLET | $5.61 | EA | Brand | — | 2026-10-21 |
| 00597029059SYNJARDY XR 5-1,000 MG TABLET | $5.61 | EA | Brand | — | 2026-10-21 |
| 00597030045SYNJARDY XR 12.5-1,000 MG TAB | $5.60 | EA | Brand | — | 2026-10-21 |
| 00597030093SYNJARDY XR 12.5-1,000 MG TAB | $5.60 | EA | Brand | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7579449 | Aug 1, 2028PED: Feb 1, 2029 | PED | Yes | — | — | — |
| 7713938 | Apr 15, 2027PED: Oct 15, 2027 | PED | Yes | Yes | — | — |
| 9949997 | May 17, 2034PED: Nov 17, 2034 | PED | — | — | — | |
| 9949997 | May 17, 2034PED: Nov 17, 2034 | PED | — | — | — | |
| 9949998 | Jun 11, 2034PED: Dec 11, 2034 | PED | — | — | — | |
| 10258637 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 10596120 | Mar 7, 2032PED: Sep 7, 2032 | PED | — | Yes | — | |
| 10596120 | Mar 7, 2032PED: Sep 7, 2032 | PED | — | Yes | — | |
| 11090323 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 11666590 | Apr 3, 2034 | — | — | — | — | |
| 11813275 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 11833166 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 11833166 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 12115179 | Feb 11, 2030PED: Aug 11, 2030 | PED | — | — | — | |
| 12263153 | Apr 3, 2034 | — | — | — | — | |
| 12427162 | Apr 3, 2034 | — | — | — | — | |
| 12433906 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 12433906 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 12433906 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 12433906 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — | |
| 12433906 | Apr 3, 2034PED: Oct 3, 2034 | PED | — | — | — |
| Code | Date | Status |
|---|---|---|
| M-296 | Jun 20, 2026 | Expired |
| PED | Dec 20, 2026 | < 1 year |